Technology ID
TT-0111
Description
Genome editing-based approaches to target the genetic cause of familial alzheimer’s disease (FAD) and abolish the expression of FAD risk genes. The genome editing technology can be applied to other inherited diseases.
Content
Highly specific genome editing that only targets the mutated gene allele to halt disease progression
First in the world to achieve non-invasive brain-wide genome editing approach
Universal genome editing approach for disease mutations based on genome-wide association studies
Inventors
Applicable Industries
Potential Application
Technology Focus
TRL
Images
